These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21895525)

  • 1. Multiple arrhythmic syndromes in a newborn, owing to a novel mutation in SCN5A.
    Calloe K; Schmitt N; Grubb S; Pfeiffer R; David JP; Kanter R; Cordeiro JM; Antzelevitch C
    Can J Physiol Pharmacol; 2011 Oct; 89(10):723-36. PubMed ID: 21895525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
    Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
    Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
    Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
    Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel SCN5A mutation V1340I in Brugada syndrome augmenting arrhythmias during febrile illness.
    Samani K; Wu G; Ai T; Shuraih M; Mathuria NS; Li Z; Sohma Y; Purevjav E; Xi Y; Towbin JA; Cheng J; Vatta M
    Heart Rhythm; 2009 Sep; 6(9):1318-26. PubMed ID: 19648062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
    Liu J; Bayer JD; Aschar-Sobbi R; Wauchop M; Spears D; Gollob M; Vigmond EJ; Tsushima R; Backx PH; Chauhan VS
    PLoS One; 2018; 13(5):e0197273. PubMed ID: 29791480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel.
    Abriel H; Cabo C; Wehrens XH; Rivolta I; Motoike HK; Memmi M; Napolitano C; Priori SG; Kass RS
    Circ Res; 2001 Apr; 88(7):740-5. PubMed ID: 11304498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A truncating SCN5A mutation combined with genetic variability causes sick sinus syndrome and early atrial fibrillation.
    Ziyadeh-Isleem A; Clatot J; Duchatelet S; Gandjbakhch E; Denjoy I; Hidden-Lucet F; Hatem S; Deschênes I; Coulombe A; Neyroud N; Guicheney P
    Heart Rhythm; 2014 Jun; 11(6):1015-1023. PubMed ID: 24582607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation.
    Keller DI; Acharfi S; Delacrétaz E; Benammar N; Rotter M; Pfammatter JP; Fressart V; Guicheney P; Chahine M
    J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations.
    Keller DI; Rougier JS; Kucera JP; Benammar N; Fressart V; Guicheney P; Madle A; Fromer M; Schläpfer J; Abriel H
    Cardiovasc Res; 2005 Aug; 67(3):510-9. PubMed ID: 15890323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.
    Hu D; Barajas-Martínez H; Medeiros-Domingo A; Crotti L; Veltmann C; Schimpf R; Urrutia J; Alday A; Casis O; Pfeiffer R; Burashnikov E; Caceres G; Tester DJ; Wolpert C; Borggrefe M; Schwartz P; Ackerman MJ; Antzelevitch C
    Heart Rhythm; 2012 May; 9(5):760-9. PubMed ID: 22155597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial expression defect for the SCN5A missense mutation G1406R depends on splice variant background Q1077 and rescue by mexiletine.
    Tan BH; Valdivia CR; Song C; Makielski JC
    Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1822-8. PubMed ID: 16632547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation.
    Makita N; Horie M; Nakamura T; Ai T; Sasaki K; Yokoi H; Sakurai M; Sakuma I; Otani H; Sawa H; Kitabatake A
    Circulation; 2002 Sep; 106(10):1269-74. PubMed ID: 12208804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction.
    Hu D; Viskin S; Oliva A; Carrier T; Cordeiro JM; Barajas-Martinez H; Wu Y; Burashnikov E; Sicouri S; Brugada R; Rosso R; Guerchicoff A; Pollevick GD; Antzelevitch C
    Heart Rhythm; 2007 Aug; 4(8):1072-80. PubMed ID: 17675083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent biophysical defects caused by mutant sodium channels in dilated cardiomyopathy with arrhythmia.
    Nguyen TP; Wang DW; Rhodes TH; George AL
    Circ Res; 2008 Feb; 102(3):364-71. PubMed ID: 18048769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced fast-inactivated state stability of cardiac sodium channels by a novel voltage sensor SCN5A mutation, R1632C, as a cause of atypical Brugada syndrome.
    Nakajima T; Kaneko Y; Saito A; Ota M; Iijima T; Kurabayashi M
    Heart Rhythm; 2015 Nov; 12(11):2296-304. PubMed ID: 26031372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
    Potet F; Beckermann TM; Kunic JD; George AL
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):933-41. PubMed ID: 26022185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties.
    Amin AS; Verkerk AO; Bhuiyan ZA; Wilde AA; Tan HL
    Acta Physiol Scand; 2005 Dec; 185(4):291-301. PubMed ID: 16266370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered sinoatrial node function and intra-atrial conduction in murine gain-of-function Scn5a+/ΔKPQ hearts suggest an overlap syndrome.
    Wu J; Zhang Y; Zhang X; Cheng L; Lammers WJ; Grace AA; Fraser JA; Zhang H; Huang CL; Lei M
    Am J Physiol Heart Circ Physiol; 2012 Apr; 302(7):H1510-23. PubMed ID: 22287583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav1.5 channels.
    Huang H; Priori SG; Napolitano C; O'Leary ME; Chahine M
    Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H288-99. PubMed ID: 21076026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.